XML 60 R44.htm IDEA: XBRL DOCUMENT v3.25.1
ORGANIZATION AND NATURE OF THE BUSINESS (Details) - USD ($)
1 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Financial assets   $ 66,014,811 $ 54,311,892 $ 66,014,811
Net loss     (16,183,018) $ (18,542,654)
CANA Pharmaceutical Laboratories, S.A. ("Cana") [Member]        
Cash     5,331,120  
Fair value of common stock issued $ 138,667   138,667  
Fair value of total consideration transferred     5,469,787  
Financial assets     1,796,911  
Inventory     297,340  
Property, plant and equipment     7,488,818  
Identifiable intangible assets     562,200  
Financial liabilities     (3,235,233)  
Total identifiable net assets     6,910,036  
Bargain purchase gain     $ 1,440,249  
Revenue   344,708    
Net loss   $ (1,232,732)